nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—PTGS2—Crohn's disease	0.226	1	CbGaD
Etoposide—PTGS2—Balsalazide—Crohn's disease	0.113	0.185	CbGbCtD
Etoposide—PTGS1—Balsalazide—Crohn's disease	0.0954	0.156	CbGbCtD
Etoposide—PTGS2—Mesalazine—Crohn's disease	0.0903	0.148	CbGbCtD
Etoposide—PTGS1—Mesalazine—Crohn's disease	0.0762	0.125	CbGbCtD
Etoposide—ABCC2—Sulfasalazine—Crohn's disease	0.051	0.0834	CbGbCtD
Etoposide—PTGS2—Sulfasalazine—Crohn's disease	0.0504	0.0824	CbGbCtD
Etoposide—ABCG2—Sulfasalazine—Crohn's disease	0.0461	0.0754	CbGbCtD
Etoposide—PTGS1—Sulfasalazine—Crohn's disease	0.0426	0.0696	CbGbCtD
Etoposide—CYP3A5—Sulfasalazine—Crohn's disease	0.0256	0.0418	CbGbCtD
Etoposide—ABCB1—Prednisone—Crohn's disease	0.0133	0.0217	CbGbCtD
Etoposide—CYP3A4—Prednisone—Crohn's disease	0.00797	0.013	CbGbCtD
Etoposide—ABCC2—bile—Crohn's disease	0.00581	0.115	CbGeAlD
Etoposide—GSTT1—mouth—Crohn's disease	0.00387	0.0766	CbGeAlD
Etoposide—Alopecia reversible—Mesalazine—Crohn's disease	0.00357	0.0341	CcSEcCtD
Etoposide—Myelosuppression—Mercaptopurine—Crohn's disease	0.00318	0.0304	CcSEcCtD
Etoposide—Acute leukaemia—Azathioprine—Crohn's disease	0.00311	0.0297	CcSEcCtD
Etoposide—Skin necrosis—Mesalazine—Crohn's disease	0.00232	0.0221	CcSEcCtD
Etoposide—ABCC3—gall bladder—Crohn's disease	0.00202	0.0399	CbGeAlD
Etoposide—GSTP1—gall bladder—Crohn's disease	0.00201	0.0397	CbGeAlD
Etoposide—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00193	0.0185	CcSEcCtD
Etoposide—Myelosuppression—Azathioprine—Crohn's disease	0.0019	0.0181	CcSEcCtD
Etoposide—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00184	0.0176	CcSEcCtD
Etoposide—GSTP1—mouth—Crohn's disease	0.00179	0.0353	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—Crohn's disease	0.00174	0.0343	CbGeAlD
Etoposide—GSTT1—digestive system—Crohn's disease	0.00171	0.0339	CbGeAlD
Etoposide—Nephropathy—Mesalazine—Crohn's disease	0.0017	0.0163	CcSEcCtD
Etoposide—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00168	0.016	CcSEcCtD
Etoposide—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00161	0.0154	CcSEcCtD
Etoposide—TOP2B—smooth muscle tissue—Crohn's disease	0.0016	0.0316	CbGeAlD
Etoposide—Ulcer—Mercaptopurine—Crohn's disease	0.00158	0.0151	CcSEcCtD
Etoposide—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00152	0.0145	CcSEcCtD
Etoposide—Anorectal discomfort—Mesalazine—Crohn's disease	0.00148	0.0142	CcSEcCtD
Etoposide—TOP2B—mammalian vulva—Crohn's disease	0.00144	0.0285	CbGeAlD
Etoposide—Candida infection—Mercaptopurine—Crohn's disease	0.00143	0.0136	CcSEcCtD
Etoposide—Nephropathy toxic—Mesalazine—Crohn's disease	0.00141	0.0135	CcSEcCtD
Etoposide—Mouth ulceration—Mercaptopurine—Crohn's disease	0.00135	0.0129	CcSEcCtD
Etoposide—Sepsis—Mercaptopurine—Crohn's disease	0.0013	0.0124	CcSEcCtD
Etoposide—Pigmentation disorder—Prednisone—Crohn's disease	0.00128	0.0123	CcSEcCtD
Etoposide—TOP2B—lymphoid tissue—Crohn's disease	0.00128	0.0253	CbGeAlD
Etoposide—TOP2B—digestive system—Crohn's disease	0.00126	0.025	CbGeAlD
Etoposide—Interstitial lung disease—Azathioprine—Crohn's disease	0.00126	0.012	CcSEcCtD
Etoposide—Nail disorder—Mesalazine—Crohn's disease	0.00125	0.0119	CcSEcCtD
Etoposide—Hepatotoxicity—Azathioprine—Crohn's disease	0.00115	0.011	CcSEcCtD
Etoposide—Interstitial lung disease—Mesalazine—Crohn's disease	0.00114	0.0109	CcSEcCtD
Etoposide—Rigors—Azathioprine—Crohn's disease	0.00109	0.0104	CcSEcCtD
Etoposide—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.00108	0.766	CbGdCrCtD
Etoposide—TOP2A—mammalian vulva—Crohn's disease	0.00106	0.0209	CbGeAlD
Etoposide—Hepatotoxicity—Mesalazine—Crohn's disease	0.00105	0.01	CcSEcCtD
Etoposide—GSTP1—epithelium—Crohn's disease	0.00104	0.0206	CbGeAlD
Etoposide—UGT1A1—digestive system—Crohn's disease	0.00101	0.0199	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—Crohn's disease	0.001	0.0198	CbGeAlD
Etoposide—GSTP1—skin of body—Crohn's disease	0.000989	0.0196	CbGeAlD
Etoposide—PTGS2—gall bladder—Crohn's disease	0.000938	0.0185	CbGeAlD
Etoposide—GSTP1—mammalian vulva—Crohn's disease	0.000902	0.0178	CbGeAlD
Etoposide—ABCC10—mammalian vulva—Crohn's disease	0.000901	0.0178	CbGeAlD
Etoposide—Skin discolouration—Mesalazine—Crohn's disease	0.000897	0.00857	CcSEcCtD
Etoposide—Pancytopenia—Mercaptopurine—Crohn's disease	0.000889	0.00849	CcSEcCtD
Etoposide—PTGS2—mouth—Crohn's disease	0.000834	0.0165	CbGeAlD
Etoposide—Stomatitis—Mercaptopurine—Crohn's disease	0.000814	0.00777	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00081	0.00774	CcSEcCtD
Etoposide—GSTP1—lymphoid tissue—Crohn's disease	0.000801	0.0158	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—Crohn's disease	0.0008	0.0158	CbGeAlD
Etoposide—ABCC3—digestive system—Crohn's disease	0.000794	0.0157	CbGeAlD
Etoposide—GSTP1—digestive system—Crohn's disease	0.000791	0.0156	CbGeAlD
Etoposide—ABCC10—digestive system—Crohn's disease	0.00079	0.0156	CbGeAlD
Etoposide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00079	0.00754	CcSEcCtD
Etoposide—Candida infection—Mesalazine—Crohn's disease	0.000774	0.00739	CcSEcCtD
Etoposide—Skin exfoliation—Mesalazine—Crohn's disease	0.000774	0.00739	CcSEcCtD
Etoposide—Neuropathy—Mesalazine—Crohn's disease	0.000761	0.00726	CcSEcCtD
Etoposide—Mouth ulceration—Mesalazine—Crohn's disease	0.000733	0.007	CcSEcCtD
Etoposide—TOP2B—lymph node—Crohn's disease	0.000721	0.0143	CbGeAlD
Etoposide—Febrile neutropenia—Prednisone—Crohn's disease	0.000713	0.0068	CcSEcCtD
Etoposide—Optic neuritis—Prednisone—Crohn's disease	0.000697	0.00666	CcSEcCtD
Etoposide—Immune system disorder—Mercaptopurine—Crohn's disease	0.000677	0.00647	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000676	0.00646	CcSEcCtD
Etoposide—Alopecia—Mercaptopurine—Crohn's disease	0.000662	0.00633	CcSEcCtD
Etoposide—ABCC1—mammalian vulva—Crohn's disease	0.000637	0.0126	CbGeAlD
Etoposide—ABCC2—digestive system—Crohn's disease	0.000635	0.0126	CbGeAlD
Etoposide—Anaemia—Mercaptopurine—Crohn's disease	0.000603	0.00576	CcSEcCtD
Etoposide—Leukopenia—Mercaptopurine—Crohn's disease	0.000584	0.00558	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000581	0.00555	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000552	0.00527	CcSEcCtD
Etoposide—Necrosis—Prednisone—Crohn's disease	0.000546	0.00522	CcSEcCtD
Etoposide—TOP2A—lymph node—Crohn's disease	0.00053	0.0105	CbGeAlD
Etoposide—Pancytopenia—Azathioprine—Crohn's disease	0.00053	0.00506	CcSEcCtD
Etoposide—Cramp muscle—Mesalazine—Crohn's disease	0.00053	0.00506	CcSEcCtD
Etoposide—ABCG2—mammalian vulva—Crohn's disease	0.000528	0.0104	CbGeAlD
Etoposide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000521	0.00498	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000519	0.00495	CcSEcCtD
Etoposide—Skin disorder—Mercaptopurine—Crohn's disease	0.000517	0.00494	CcSEcCtD
Etoposide—Dysphagia—Mesalazine—Crohn's disease	0.000508	0.00485	CcSEcCtD
Etoposide—Anorexia—Mercaptopurine—Crohn's disease	0.000508	0.00485	CcSEcCtD
Etoposide—PTGS1—epithelium—Crohn's disease	0.000507	0.01	CbGeAlD
Etoposide—Pneumonia—Azathioprine—Crohn's disease	0.0005	0.00478	CcSEcCtD
Etoposide—Bronchospasm—Mesalazine—Crohn's disease	0.0005	0.00477	CcSEcCtD
Etoposide—Infestation—Azathioprine—Crohn's disease	0.000498	0.00475	CcSEcCtD
Etoposide—Infestation NOS—Azathioprine—Crohn's disease	0.000498	0.00475	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000493	0.00471	CcSEcCtD
Etoposide—PTGS1—smooth muscle tissue—Crohn's disease	0.000489	0.00967	CbGeAlD
Etoposide—PTGS2—epithelium—Crohn's disease	0.000485	0.00959	CbGeAlD
Etoposide—Pancytopenia—Mesalazine—Crohn's disease	0.000483	0.00461	CcSEcCtD
Etoposide—PTGS1—skin of body—Crohn's disease	0.000483	0.00954	CbGeAlD
Etoposide—Neutropenia—Mesalazine—Crohn's disease	0.000475	0.00454	CcSEcCtD
Etoposide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000471	0.00449	CcSEcCtD
Etoposide—PTGS2—smooth muscle tissue—Crohn's disease	0.000467	0.00924	CbGeAlD
Etoposide—Agranulocytosis—Azathioprine—Crohn's disease	0.000464	0.00443	CcSEcCtD
Etoposide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000463	0.00442	CcSEcCtD
Etoposide—PTGS2—skin of body—Crohn's disease	0.000461	0.00912	CbGeAlD
Etoposide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00046	0.00439	CcSEcCtD
Etoposide—Pneumonia—Mesalazine—Crohn's disease	0.000456	0.00435	CcSEcCtD
Etoposide—ABCC3—lymph node—Crohn's disease	0.000454	0.00897	CbGeAlD
Etoposide—Infestation NOS—Mesalazine—Crohn's disease	0.000453	0.00433	CcSEcCtD
Etoposide—Infestation—Mesalazine—Crohn's disease	0.000453	0.00433	CcSEcCtD
Etoposide—Ulcer—Prednisone—Crohn's disease	0.000453	0.00433	CcSEcCtD
Etoposide—GSTP1—lymph node—Crohn's disease	0.000452	0.00893	CbGeAlD
Etoposide—ABCC10—lymph node—Crohn's disease	0.000452	0.00893	CbGeAlD
Etoposide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000449	0.00429	CcSEcCtD
Etoposide—Renal failure—Mesalazine—Crohn's disease	0.000446	0.00425	CcSEcCtD
Etoposide—CYP1A2—digestive system—Crohn's disease	0.000445	0.00881	CbGeAlD
Etoposide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000444	0.00424	CcSEcCtD
Etoposide—Stomatitis—Mesalazine—Crohn's disease	0.000442	0.00422	CcSEcCtD
Etoposide—Jaundice—Mesalazine—Crohn's disease	0.000442	0.00422	CcSEcCtD
Etoposide—PTGS1—mammalian vulva—Crohn's disease	0.00044	0.0087	CbGeAlD
Etoposide—CYP3A5—digestive system—Crohn's disease	0.00043	0.0085	CbGeAlD
Etoposide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000429	0.00409	CcSEcCtD
Etoposide—Agranulocytosis—Mesalazine—Crohn's disease	0.000423	0.00404	CcSEcCtD
Etoposide—Erythema multiforme—Azathioprine—Crohn's disease	0.000422	0.00403	CcSEcCtD
Etoposide—Body temperature increased—Mercaptopurine—Crohn's disease	0.000421	0.00402	CcSEcCtD
Etoposide—Skin exfoliation—Prednisone—Crohn's disease	0.000409	0.00391	CcSEcCtD
Etoposide—CYP2E1—lymphoid tissue—Crohn's disease	0.000406	0.00802	CbGeAlD
Etoposide—Immune system disorder—Azathioprine—Crohn's disease	0.000403	0.00385	CcSEcCtD
Etoposide—Mediastinal disorder—Azathioprine—Crohn's disease	0.000403	0.00384	CcSEcCtD
Etoposide—Neuropathy—Prednisone—Crohn's disease	0.000402	0.00384	CcSEcCtD
Etoposide—Urinary tract disorder—Mesalazine—Crohn's disease	0.000402	0.00384	CcSEcCtD
Etoposide—Chills—Azathioprine—Crohn's disease	0.000401	0.00383	CcSEcCtD
Etoposide—CYP2E1—digestive system—Crohn's disease	0.000401	0.00792	CbGeAlD
Etoposide—Urethral disorder—Mesalazine—Crohn's disease	0.000399	0.00381	CcSEcCtD
Etoposide—Alopecia—Azathioprine—Crohn's disease	0.000395	0.00377	CcSEcCtD
Etoposide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000392	0.00375	CcSEcCtD
Etoposide—Oesophagitis—Prednisone—Crohn's disease	0.000392	0.00374	CcSEcCtD
Etoposide—PTGS1—digestive system—Crohn's disease	0.000386	0.00763	CbGeAlD
Etoposide—Erythema multiforme—Mesalazine—Crohn's disease	0.000385	0.00367	CcSEcCtD
Etoposide—Eye disorder—Mesalazine—Crohn's disease	0.00038	0.00363	CcSEcCtD
Etoposide—Cardiac disorder—Mesalazine—Crohn's disease	0.000378	0.00361	CcSEcCtD
Etoposide—PTGS2—lymphoid tissue—Crohn's disease	0.000374	0.00739	CbGeAlD
Etoposide—Sepsis—Prednisone—Crohn's disease	0.000372	0.00355	CcSEcCtD
Etoposide—Angiopathy—Mesalazine—Crohn's disease	0.000369	0.00353	CcSEcCtD
Etoposide—PTGS2—digestive system—Crohn's disease	0.000369	0.0073	CbGeAlD
Etoposide—Immune system disorder—Mesalazine—Crohn's disease	0.000368	0.00351	CcSEcCtD
Etoposide—Mediastinal disorder—Mesalazine—Crohn's disease	0.000367	0.0035	CcSEcCtD
Etoposide—Chills—Mesalazine—Crohn's disease	0.000365	0.00349	CcSEcCtD
Etoposide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000364	0.00348	CcSEcCtD
Etoposide—ABCC2—lymph node—Crohn's disease	0.000363	0.00717	CbGeAlD
Etoposide—Ill-defined disorder—Azathioprine—Crohn's disease	0.000361	0.00345	CcSEcCtD
Etoposide—Alopecia—Mesalazine—Crohn's disease	0.00036	0.00343	CcSEcCtD
Etoposide—Anaemia—Azathioprine—Crohn's disease	0.000359	0.00343	CcSEcCtD
Etoposide—Malaise—Azathioprine—Crohn's disease	0.000351	0.00335	CcSEcCtD
Etoposide—Leukopenia—Azathioprine—Crohn's disease	0.000348	0.00332	CcSEcCtD
Etoposide—Dysgeusia—Mesalazine—Crohn's disease	0.000347	0.00331	CcSEcCtD
Etoposide—Cardiac failure congestive—Prednisone—Crohn's disease	0.000343	0.00328	CcSEcCtD
Etoposide—Back pain—Mesalazine—Crohn's disease	0.000343	0.00327	CcSEcCtD
Etoposide—Muscle spasms—Mesalazine—Crohn's disease	0.000341	0.00325	CcSEcCtD
Etoposide—Vomiting—Mercaptopurine—Crohn's disease	0.000339	0.00323	CcSEcCtD
Etoposide—Rash—Mercaptopurine—Crohn's disease	0.000336	0.00321	CcSEcCtD
Etoposide—Dermatitis—Mercaptopurine—Crohn's disease	0.000336	0.0032	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.000331	0.234	CbGdCrCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000329	0.00314	CcSEcCtD
Etoposide—Ill-defined disorder—Mesalazine—Crohn's disease	0.000329	0.00314	CcSEcCtD
Etoposide—Anaemia—Mesalazine—Crohn's disease	0.000327	0.00313	CcSEcCtD
Etoposide—Discomfort—Azathioprine—Crohn's disease	0.000327	0.00312	CcSEcCtD
Etoposide—CYP3A4—digestive system—Crohn's disease	0.000322	0.00638	CbGeAlD
Etoposide—Malaise—Mesalazine—Crohn's disease	0.000319	0.00305	CcSEcCtD
Etoposide—ABCC1—lymph node—Crohn's disease	0.000319	0.00631	CbGeAlD
Etoposide—Cardiac failure—Prednisone—Crohn's disease	0.000319	0.00304	CcSEcCtD
Etoposide—Vertigo—Mesalazine—Crohn's disease	0.000318	0.00304	CcSEcCtD
Etoposide—Leukopenia—Mesalazine—Crohn's disease	0.000317	0.00303	CcSEcCtD
Etoposide—Nausea—Mercaptopurine—Crohn's disease	0.000316	0.00302	CcSEcCtD
Etoposide—Infection—Azathioprine—Crohn's disease	0.000315	0.00301	CcSEcCtD
Etoposide—Loss of consciousness—Mesalazine—Crohn's disease	0.000311	0.00297	CcSEcCtD
Etoposide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000311	0.00297	CcSEcCtD
Etoposide—Cough—Mesalazine—Crohn's disease	0.000309	0.00295	CcSEcCtD
Etoposide—Skin disorder—Azathioprine—Crohn's disease	0.000308	0.00294	CcSEcCtD
Etoposide—Hypertension—Mesalazine—Crohn's disease	0.000306	0.00292	CcSEcCtD
Etoposide—Chest pain—Mesalazine—Crohn's disease	0.000302	0.00288	CcSEcCtD
Etoposide—ABCB1—epithelium—Crohn's disease	0.0003	0.00593	CbGeAlD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000299	0.00286	CcSEcCtD
Etoposide—Discomfort—Mesalazine—Crohn's disease	0.000298	0.00285	CcSEcCtD
Etoposide—Hypotension—Azathioprine—Crohn's disease	0.000297	0.00283	CcSEcCtD
Etoposide—Cardiac arrest—Prednisone—Crohn's disease	0.000296	0.00283	CcSEcCtD
Etoposide—Confusional state—Mesalazine—Crohn's disease	0.000291	0.00278	CcSEcCtD
Etoposide—Anaphylactic shock—Mesalazine—Crohn's disease	0.000289	0.00276	CcSEcCtD
Etoposide—Infection—Mesalazine—Crohn's disease	0.000287	0.00274	CcSEcCtD
Etoposide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000283	0.0027	CcSEcCtD
Etoposide—Tachycardia—Mesalazine—Crohn's disease	0.000282	0.00269	CcSEcCtD
Etoposide—Skin disorder—Mesalazine—Crohn's disease	0.000281	0.00268	CcSEcCtD
Etoposide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000279	0.00267	CcSEcCtD
Etoposide—Anorexia—Mesalazine—Crohn's disease	0.000276	0.00263	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000274	0.00262	CcSEcCtD
Etoposide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000274	0.00262	CcSEcCtD
Etoposide—Hypotension—Mesalazine—Crohn's disease	0.00027	0.00258	CcSEcCtD
Etoposide—ABCG2—lymph node—Crohn's disease	0.000264	0.00523	CbGeAlD
Etoposide—Sweating increased—Prednisone—Crohn's disease	0.000262	0.0025	CcSEcCtD
Etoposide—Feeling abnormal—Azathioprine—Crohn's disease	0.000262	0.0025	CcSEcCtD
Etoposide—ABCB1—mammalian vulva—Crohn's disease	0.00026	0.00515	CbGeAlD
Etoposide—Paraesthesia—Mesalazine—Crohn's disease	0.00026	0.00248	CcSEcCtD
Etoposide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00026	0.00248	CcSEcCtD
Etoposide—Dyspnoea—Mesalazine—Crohn's disease	0.000258	0.00246	CcSEcCtD
Etoposide—Somnolence—Mesalazine—Crohn's disease	0.000257	0.00245	CcSEcCtD
Etoposide—Neutropenia—Prednisone—Crohn's disease	0.000251	0.0024	CcSEcCtD
Etoposide—Decreased appetite—Mesalazine—Crohn's disease	0.000251	0.0024	CcSEcCtD
Etoposide—Abdominal pain—Azathioprine—Crohn's disease	0.000251	0.0024	CcSEcCtD
Etoposide—Body temperature increased—Azathioprine—Crohn's disease	0.000251	0.0024	CcSEcCtD
Etoposide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00025	0.00238	CcSEcCtD
Etoposide—Fatigue—Mesalazine—Crohn's disease	0.000249	0.00238	CcSEcCtD
Etoposide—Constipation—Mesalazine—Crohn's disease	0.000247	0.00236	CcSEcCtD
Etoposide—Pain—Mesalazine—Crohn's disease	0.000247	0.00236	CcSEcCtD
Etoposide—Feeling abnormal—Mesalazine—Crohn's disease	0.000238	0.00227	CcSEcCtD
Etoposide—Acute coronary syndrome—Prednisone—Crohn's disease	0.000236	0.00226	CcSEcCtD
Etoposide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000236	0.00226	CcSEcCtD
Etoposide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000235	0.00224	CcSEcCtD
Etoposide—Myocardial infarction—Prednisone—Crohn's disease	0.000235	0.00224	CcSEcCtD
Etoposide—Hypersensitivity—Azathioprine—Crohn's disease	0.000234	0.00223	CcSEcCtD
Etoposide—ABCB1—lymphoid tissue—Crohn's disease	0.000231	0.00457	CbGeAlD
Etoposide—Urticaria—Mesalazine—Crohn's disease	0.00023	0.00219	CcSEcCtD
Etoposide—Body temperature increased—Mesalazine—Crohn's disease	0.000229	0.00218	CcSEcCtD
Etoposide—Abdominal pain—Mesalazine—Crohn's disease	0.000229	0.00218	CcSEcCtD
Etoposide—ABCB1—digestive system—Crohn's disease	0.000228	0.00451	CbGeAlD
Etoposide—PTGS1—lymph node—Crohn's disease	0.000221	0.00436	CbGeAlD
Etoposide—Diarrhoea—Azathioprine—Crohn's disease	0.000217	0.00207	CcSEcCtD
Etoposide—Hypersensitivity—Mesalazine—Crohn's disease	0.000213	0.00203	CcSEcCtD
Etoposide—PTGS2—lymph node—Crohn's disease	0.000211	0.00417	CbGeAlD
Etoposide—Dizziness—Azathioprine—Crohn's disease	0.00021	0.002	CcSEcCtD
Etoposide—Asthenia—Mesalazine—Crohn's disease	0.000207	0.00198	CcSEcCtD
Etoposide—Pruritus—Mesalazine—Crohn's disease	0.000205	0.00195	CcSEcCtD
Etoposide—Vomiting—Azathioprine—Crohn's disease	0.000202	0.00193	CcSEcCtD
Etoposide—Eye disorder—Prednisone—Crohn's disease	0.000201	0.00192	CcSEcCtD
Etoposide—Rash—Azathioprine—Crohn's disease	0.0002	0.00191	CcSEcCtD
Etoposide—Dermatitis—Azathioprine—Crohn's disease	0.0002	0.00191	CcSEcCtD
Etoposide—Flushing—Prednisone—Crohn's disease	0.0002	0.00191	CcSEcCtD
Etoposide—Headache—Azathioprine—Crohn's disease	0.000199	0.0019	CcSEcCtD
Etoposide—Diarrhoea—Mesalazine—Crohn's disease	0.000198	0.00189	CcSEcCtD
Etoposide—Angiopathy—Prednisone—Crohn's disease	0.000195	0.00187	CcSEcCtD
Etoposide—Immune system disorder—Prednisone—Crohn's disease	0.000194	0.00186	CcSEcCtD
Etoposide—Dizziness—Mesalazine—Crohn's disease	0.000191	0.00183	CcSEcCtD
Etoposide—Alopecia—Prednisone—Crohn's disease	0.00019	0.00182	CcSEcCtD
Etoposide—Nausea—Azathioprine—Crohn's disease	0.000189	0.0018	CcSEcCtD
Etoposide—Vomiting—Mesalazine—Crohn's disease	0.000184	0.00176	CcSEcCtD
Etoposide—Rash—Mesalazine—Crohn's disease	0.000182	0.00174	CcSEcCtD
Etoposide—Dermatitis—Mesalazine—Crohn's disease	0.000182	0.00174	CcSEcCtD
Etoposide—Headache—Mesalazine—Crohn's disease	0.000181	0.00173	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—Crohn's disease	0.000174	0.00166	CcSEcCtD
Etoposide—Anaemia—Prednisone—Crohn's disease	0.000173	0.00165	CcSEcCtD
Etoposide—Nausea—Mesalazine—Crohn's disease	0.000172	0.00164	CcSEcCtD
Etoposide—Malaise—Prednisone—Crohn's disease	0.000169	0.00161	CcSEcCtD
Etoposide—Vertigo—Prednisone—Crohn's disease	0.000168	0.00161	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—Crohn's disease	0.000165	0.00157	CcSEcCtD
Etoposide—Convulsion—Prednisone—Crohn's disease	0.000162	0.00155	CcSEcCtD
Etoposide—Hypertension—Prednisone—Crohn's disease	0.000162	0.00155	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000158	0.00151	CcSEcCtD
Etoposide—Discomfort—Prednisone—Crohn's disease	0.000158	0.00151	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—Crohn's disease	0.000153	0.00146	CcSEcCtD
Etoposide—Infection—Prednisone—Crohn's disease	0.000152	0.00145	CcSEcCtD
Etoposide—Tachycardia—Prednisone—Crohn's disease	0.000149	0.00143	CcSEcCtD
Etoposide—Skin disorder—Prednisone—Crohn's disease	0.000149	0.00142	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—Crohn's disease	0.000148	0.00141	CcSEcCtD
Etoposide—Anorexia—Prednisone—Crohn's disease	0.000146	0.00139	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—Crohn's disease	0.000137	0.00131	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—Crohn's disease	0.000133	0.00127	CcSEcCtD
Etoposide—Fatigue—Prednisone—Crohn's disease	0.000132	0.00126	CcSEcCtD
Etoposide—Constipation—Prednisone—Crohn's disease	0.000131	0.00125	CcSEcCtD
Etoposide—ABCB1—lymph node—Crohn's disease	0.00013	0.00258	CbGeAlD
Etoposide—Feeling abnormal—Prednisone—Crohn's disease	0.000126	0.0012	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000125	0.00119	CcSEcCtD
Etoposide—Urticaria—Prednisone—Crohn's disease	0.000122	0.00116	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—Crohn's disease	0.000121	0.00115	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—Crohn's disease	0.000121	0.00115	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—Crohn's disease	0.000113	0.00108	CcSEcCtD
Etoposide—Asthenia—Prednisone—Crohn's disease	0.00011	0.00105	CcSEcCtD
Etoposide—Pruritus—Prednisone—Crohn's disease	0.000108	0.00103	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—Crohn's disease	0.000105	0.000999	CcSEcCtD
Etoposide—Dizziness—Prednisone—Crohn's disease	0.000101	0.000966	CcSEcCtD
Etoposide—Vomiting—Prednisone—Crohn's disease	9.72e-05	0.000929	CcSEcCtD
Etoposide—Rash—Prednisone—Crohn's disease	9.64e-05	0.000921	CcSEcCtD
Etoposide—Dermatitis—Prednisone—Crohn's disease	9.63e-05	0.00092	CcSEcCtD
Etoposide—Headache—Prednisone—Crohn's disease	9.58e-05	0.000915	CcSEcCtD
Etoposide—Nausea—Prednisone—Crohn's disease	9.08e-05	0.000868	CcSEcCtD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	1.9e-05	0.0038	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GPX4—Crohn's disease	1.87e-05	0.00373	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.85e-05	0.0037	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.85e-05	0.0037	CbGpPWpGaD
Etoposide—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	1.82e-05	0.00364	CbGpPWpGaD
Etoposide—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	1.81e-05	0.00361	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GCKR—Crohn's disease	1.81e-05	0.00361	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL17A—Crohn's disease	1.81e-05	0.0036	CbGpPWpGaD
Etoposide—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	1.8e-05	0.0036	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.8e-05	0.00359	CbGpPWpGaD
Etoposide—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.77e-05	0.00354	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	1.68e-05	0.00336	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL12B—Crohn's disease	1.68e-05	0.00335	CbGpPWpGaD
Etoposide—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	1.66e-05	0.00332	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PLA2G4F—Crohn's disease	1.65e-05	0.0033	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.57e-05	0.00313	CbGpPWpGaD
Etoposide—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	1.56e-05	0.00312	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.55e-05	0.00309	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.53e-05	0.00305	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.52e-05	0.00303	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.52e-05	0.00303	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.47e-05	0.00293	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.47e-05	0.00293	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	1.47e-05	0.00293	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.45e-05	0.0029	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.45e-05	0.0029	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.42e-05	0.00284	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—MTMR3—Crohn's disease	1.41e-05	0.0028	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	1.36e-05	0.00272	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	1.36e-05	0.00272	CbGpPWpGaD
Etoposide—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	1.35e-05	0.00269	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	1.33e-05	0.00266	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.31e-05	0.00261	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.29e-05	0.00258	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.29e-05	0.00257	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.28e-05	0.00255	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.28e-05	0.00255	CbGpPWpGaD
Etoposide—ABCC6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.23e-05	0.00245	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.23e-05	0.00245	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL10—Crohn's disease	1.23e-05	0.00245	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.21e-05	0.00241	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	1.2e-05	0.00239	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.19e-05	0.00238	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	1.18e-05	0.00235	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.15e-05	0.0023	CbGpPWpGaD
Etoposide—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.14e-05	0.00229	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.13e-05	0.00225	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.11e-05	0.00222	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CXCL8—Crohn's disease	1.11e-05	0.00221	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—FADS1—Crohn's disease	1.09e-05	0.00219	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	1.09e-05	0.00218	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	1.09e-05	0.00217	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.09e-05	0.00217	CbGpPWpGaD
Etoposide—ABCC10—Transmembrane transport of small molecules—ALB—Crohn's disease	1.07e-05	0.00214	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—UBE2D1—Crohn's disease	1.07e-05	0.00214	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	1.05e-05	0.00209	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.04e-05	0.00207	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.04e-05	0.00207	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GPX4—Crohn's disease	1.03e-05	0.00205	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.03e-05	0.00205	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.02e-05	0.00204	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.02e-05	0.00204	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PLA2G4F—Crohn's disease	1.02e-05	0.00204	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.02e-05	0.00203	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.01e-05	0.00202	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.01e-05	0.00201	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GCKR—Crohn's disease	9.9e-06	0.00198	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.81e-06	0.00196	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	9.7e-06	0.00194	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	9.5e-06	0.0019	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.42e-06	0.00188	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	9.36e-06	0.00187	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	9.34e-06	0.00186	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.15e-06	0.00183	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.04e-06	0.00181	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	9e-06	0.0018	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—STAT3—Crohn's disease	8.92e-06	0.00178	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	8.88e-06	0.00177	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—MTMR3—Crohn's disease	8.68e-06	0.00173	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	8.51e-06	0.0017	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	8.39e-06	0.00167	CbGpPWpGaD
Etoposide—ABCC1—Disease—RSPO3—Crohn's disease	8.35e-06	0.00167	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.34e-06	0.00166	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	8.33e-06	0.00166	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	8.3e-06	0.00166	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PLA2G4F—Crohn's disease	8e-06	0.0016	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.99e-06	0.00159	CbGpPWpGaD
Etoposide—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.96e-06	0.00159	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.96e-06	0.00159	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	7.92e-06	0.00158	CbGpPWpGaD
Etoposide—ABCC1—Disease—SEL1L—Crohn's disease	7.92e-06	0.00158	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	7.7e-06	0.00154	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	7.61e-06	0.00152	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.48e-06	0.00149	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	7.38e-06	0.00147	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IFNG—Crohn's disease	7.22e-06	0.00144	CbGpPWpGaD
Etoposide—ABCC1—Disease—LTF—Crohn's disease	7.1e-06	0.00142	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—MTMR3—Crohn's disease	7.05e-06	0.00141	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PLA2G4F—Crohn's disease	7.04e-06	0.00141	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7e-06	0.0014	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.91e-06	0.00138	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.91e-06	0.00138	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	6.87e-06	0.00137	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.82e-06	0.00136	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—MTMR3—Crohn's disease	6.8e-06	0.00136	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—FADS1—Crohn's disease	6.76e-06	0.00135	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PLA2G4F—Crohn's disease	6.76e-06	0.00135	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	6.71e-06	0.00134	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	6.59e-06	0.00131	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.5e-06	0.0013	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.44e-06	0.00128	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GPX4—Crohn's disease	6.33e-06	0.00126	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—IL6—Crohn's disease	6.23e-06	0.00124	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	6.14e-06	0.00123	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GCKR—Crohn's disease	6.12e-06	0.00122	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.08e-06	0.00121	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	6.04e-06	0.00121	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—MTMR3—Crohn's disease	5.99e-06	0.00119	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.8e-06	0.00116	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—MTMR3—Crohn's disease	5.75e-06	0.00115	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ALB—Crohn's disease	5.75e-06	0.00115	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.75e-06	0.00115	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.75e-06	0.00115	CbGpPWpGaD
Etoposide—ABCC1—Disease—GCKR—Crohn's disease	5.72e-06	0.00114	CbGpPWpGaD
Etoposide—PTGS2—Disease—RSPO3—Crohn's disease	5.6e-06	0.00112	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—FADS1—Crohn's disease	5.5e-06	0.0011	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	5.42e-06	0.00108	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PLA2G4F—Crohn's disease	5.37e-06	0.00107	CbGpPWpGaD
Etoposide—PTGS2—Disease—SEL1L—Crohn's disease	5.31e-06	0.00106	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—FADS1—Crohn's disease	5.3e-06	0.00106	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GPX4—Crohn's disease	5.15e-06	0.00103	CbGpPWpGaD
Etoposide—ABCC1—Disease—SLC11A1—Crohn's disease	5.06e-06	0.00101	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	5.05e-06	0.00101	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	5.04e-06	0.00101	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—Crohn's disease	5.03e-06	0.001	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GCKR—Crohn's disease	4.97e-06	0.000992	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GPX4—Crohn's disease	4.96e-06	0.000991	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	4.88e-06	0.000973	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.87e-06	0.000972	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GCKR—Crohn's disease	4.79e-06	0.000957	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	4.78e-06	0.000954	CbGpPWpGaD
Etoposide—PTGS2—Disease—LTF—Crohn's disease	4.76e-06	0.000951	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.67e-06	0.000932	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—FADS1—Crohn's disease	4.66e-06	0.000931	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTMR3—Crohn's disease	4.56e-06	0.000911	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.52e-06	0.000902	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—FADS1—Crohn's disease	4.48e-06	0.000894	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.37e-06	0.000872	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	4.37e-06	0.000872	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GPX4—Crohn's disease	4.37e-06	0.000872	CbGpPWpGaD
Etoposide—ABCC1—Disease—RBX1—Crohn's disease	4.34e-06	0.000866	CbGpPWpGaD
Etoposide—ABCC1—Disease—HSPA1B—Crohn's disease	4.34e-06	0.000866	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.3e-06	0.000859	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTMR3—Crohn's disease	4.3e-06	0.000858	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTMR3—Crohn's disease	4.29e-06	0.000856	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.23e-06	0.000845	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GCKR—Crohn's disease	4.22e-06	0.000842	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GPX4—Crohn's disease	4.2e-06	0.000837	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.16e-06	0.00083	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GCKR—Crohn's disease	4.05e-06	0.000809	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	3.86e-06	0.00077	CbGpPWpGaD
Etoposide—PTGS2—Disease—GCKR—Crohn's disease	3.84e-06	0.000767	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.82e-06	0.000763	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.81e-06	0.00076	CbGpPWpGaD
Etoposide—ABCC1—Disease—UBE2D1—Crohn's disease	3.8e-06	0.000759	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.71e-06	0.000741	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—FADS1—Crohn's disease	3.56e-06	0.00071	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.42e-06	0.000684	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.41e-06	0.000681	CbGpPWpGaD
Etoposide—PTGS2—Disease—SLC11A1—Crohn's disease	3.39e-06	0.000678	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—FADS1—Crohn's disease	3.35e-06	0.000668	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—FADS1—Crohn's disease	3.34e-06	0.000667	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GPX4—Crohn's disease	3.33e-06	0.000665	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.3e-06	0.000658	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.26e-06	0.00065	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.25e-06	0.000649	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTMR3—Crohn's disease	3.24e-06	0.000646	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GCKR—Crohn's disease	3.22e-06	0.000642	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ALB—Crohn's disease	3.15e-06	0.000629	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GPX4—Crohn's disease	3.13e-06	0.000626	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GPX4—Crohn's disease	3.13e-06	0.000624	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.04e-06	0.000606	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GCKR—Crohn's disease	3.03e-06	0.000604	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GCKR—Crohn's disease	3.02e-06	0.000603	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3e-06	0.000598	CbGpPWpGaD
Etoposide—PTGS2—Disease—RBX1—Crohn's disease	2.91e-06	0.000581	CbGpPWpGaD
Etoposide—PTGS2—Disease—HSPA1B—Crohn's disease	2.91e-06	0.000581	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.9e-06	0.000578	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—FADS1—Crohn's disease	2.89e-06	0.000578	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.87e-06	0.000572	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—Crohn's disease	2.76e-06	0.00055	CbGpPWpGaD
Etoposide—ABCC1—Disease—SMAD3—Crohn's disease	2.72e-06	0.000543	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPX4—Crohn's disease	2.71e-06	0.000541	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GCKR—Crohn's disease	2.62e-06	0.000522	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.58e-06	0.000516	CbGpPWpGaD
Etoposide—PTGS2—Disease—UBE2D1—Crohn's disease	2.55e-06	0.000509	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.53e-06	0.000506	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—FADS1—Crohn's disease	2.52e-06	0.000503	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPX4—Crohn's disease	2.36e-06	0.000471	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.34e-06	0.000468	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.3e-06	0.00046	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.3e-06	0.000459	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GCKR—Crohn's disease	2.28e-06	0.000455	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—FADS1—Crohn's disease	2.01e-06	0.000402	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.99e-06	0.000398	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ALB—Crohn's disease	1.95e-06	0.000389	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPX4—Crohn's disease	1.88e-06	0.000376	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.87e-06	0.000373	CbGpPWpGaD
Etoposide—PTGS2—Disease—SMAD3—Crohn's disease	1.83e-06	0.000364	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GCKR—Crohn's disease	1.82e-06	0.000363	CbGpPWpGaD
Etoposide—ABCC1—Disease—TYK2—Crohn's disease	1.77e-06	0.000354	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—Crohn's disease	1.7e-06	0.00034	CbGpPWpGaD
Etoposide—ABCC1—Disease—JAK2—Crohn's disease	1.69e-06	0.000338	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.64e-06	0.000327	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD4—Crohn's disease	1.61e-06	0.00032	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—Crohn's disease	1.59e-06	0.000318	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—Crohn's disease	1.58e-06	0.000316	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FADS1—Crohn's disease	1.55e-06	0.00031	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.55e-06	0.000309	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—Crohn's disease	1.53e-06	0.000304	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPX4—Crohn's disease	1.45e-06	0.00029	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GCKR—Crohn's disease	1.4e-06	0.00028	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—Crohn's disease	1.38e-06	0.000276	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—Crohn's disease	1.34e-06	0.000268	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—Crohn's disease	1.33e-06	0.000266	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.3e-06	0.00026	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—Crohn's disease	1.29e-06	0.000257	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—Crohn's disease	1.24e-06	0.000248	CbGpPWpGaD
Etoposide—PTGS2—Disease—TYK2—Crohn's disease	1.19e-06	0.000238	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—Crohn's disease	1.17e-06	0.000234	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.14e-06	0.000227	CbGpPWpGaD
Etoposide—PTGS2—Disease—JAK2—Crohn's disease	1.14e-06	0.000227	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—Crohn's disease	1.13e-06	0.000225	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—Crohn's disease	1.08e-06	0.000215	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—Crohn's disease	1.02e-06	0.000204	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—Crohn's disease	9.64e-07	0.000192	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—Crohn's disease	9.62e-07	0.000192	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—Crohn's disease	8.68e-07	0.000173	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—Crohn's disease	8.43e-07	0.000168	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—Crohn's disease	8.41e-07	0.000168	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—Crohn's disease	8.34e-07	0.000166	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—Crohn's disease	8.33e-07	0.000166	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—Crohn's disease	7.29e-07	0.000145	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—Crohn's disease	7.26e-07	0.000145	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—Crohn's disease	6.35e-07	0.000127	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—Crohn's disease	5.83e-07	0.000116	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—Crohn's disease	5.79e-07	0.000116	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.07e-07	0.000101	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—Crohn's disease	4.47e-07	8.92e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.91e-07	7.81e-05	CbGpPWpGaD
